KUALA LUMPUR - Malaysia’s pharmaceutical firm Pharmaniaga is hoping for government help to sell its massive Covid-19 vaccine stockpile, in what could be a litmus test for the four-month-old Anwar Ibrahim administration in managing troubled government-linked companies (GLCs).
During the pandemic, the Malaysian government directly bought vaccines such as Pfizer and AstraZeneca from manufacturers. The government also allowed Pharmaniaga to exclusively import Sinovac vaccines from China. Malaysia also took part in the Covax programme supported by World Health Organisation to buy vaccines.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
